CorRELation Between PatIent PErception and Findings on Clinical Examination
NCT ID: NCT01627743
Last Updated: 2013-02-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
505 participants
OBSERVATIONAL
2012-07-31
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patient's Perception in Symptoms Related to Morning Activity Based on Chronic Obstructive Lung Disease
NCT00894426
Symptoms and Physical Activity in COPD Patients in Europe
NCT03031769
Correlation Between Patient Perception and Findings on Clinical Examination in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01703416
Impact of Morning Symptoms in Clinical Control of Chronic Obstructive Pulmonary Disease (COPD)
NCT01266395
European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00722267
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COPD patients grade C and D
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Current or past smokers, of at least 10 pack years
* Receive any inhaled combination therapy for COPD (inhaled corticosteroid / long acting β2-agonist bronchodilator) initiated for at least one month before entering in the study
Exclusion Criteria
* Inability to understand study procedures and inability/refuse to complete CDLM questionnaires and/or record the values showed on the pedometer screen
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Florin Mihaltan, PROFESSOR
Role: PRINCIPAL_INVESTIGATOR
University of Medicine and Pharmacy Carol Davila, Bucharest, Romania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Bacau, , Romania
Research Site
Botoșani, , Romania
Research Site
Bucharest, , Romania
Research Site
Buzău, , Romania
Research Site
Călăraşi, , Romania
Research Site
Cluj-Napoca, , Romania
Research Site
Constanța, , Romania
Research Site
Craiova, , Romania
Research Site
Drobeta-Turnu Severin, , Romania
Research Site
Fălticeni, , Romania
Research Site
Focşani, , Romania
Research Site
Iași, , Romania
Research Site
Leordeni, , Romania
Research Site
Luduş, , Romania
Research Site
Oradea, , Romania
Research Site
Ploieşti, , Romania
Research Site
Râmnicu Vâlcea, , Romania
Research Site
Reghin, , Romania
Research Site
Slatina, , Romania
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-RRO-ATC-2012/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.